29 March, 2020, 06:11 PM IST



Zydus Cadila gets DCGI nod for world's first drug to treat liver disease

The Ahmedabad-based company said the approved product is the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoholic SteatoHepatitis (NASH) which is a progressive disease of the liver. The condition starts with fat accumulation in the liver known as non-alcoholic fatty liver disease and progress to cirrhosis and liver failure.

Zydus rises on regulator’s nod for drug to treat liver disease

Shares of the company closed at Rs 263.55 on the bourse.

Take up walking & cycling; physical activities can reduce risk of death from liver cirrhosis

Muscle-strengthening exercises can cut the risk ...

Load More...

Other useful Links

Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service